Ani Pharmaceuticals (ANIP) Profit After Tax Growth (3y) (2013 - 2026)
Ani Pharmaceuticals (ANIP) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 58.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.17% |
| Mar 31, 2026 | 173.66% |
| Dec 31, 2025 | 103.91% |
| Sep 30, 2025 | 72.07% |
| Jun 30, 2025 | 37.03% |
| Mar 31, 2025 | 40.33% |
| Dec 31, 2024 | 24.77% |
| Sep 30, 2024 | -75.81% |
| Jun 30, 2024 | 45.47% |
| Mar 31, 2024 | 496.00% |
| Dec 31, 2023 | 32.34% |
| Sep 30, 2023 | 177.93% |
| Jun 30, 2023 | 35.83% |
| Mar 31, 2023 | 30.16% |
| Dec 31, 2022 | 4.26% |
| Sep 30, 2022 | -61.44% |
| Jun 30, 2022 | -62.19% |
| Mar 31, 2022 | -262.75% |
| Dec 31, 2021 | -86.10% |
| Sep 30, 2021 | -42.32% |